Synthetic Biology
Examination of gene editing technologies, biosafety protocols, and international governance approaches.
Research Overview
Our Synthetic Biology research examines the governance challenges posed by rapidly advancing gene editing technologies and synthetic biology applications. We focus on developing frameworks for responsible innovation, risk assessment, and international coordination to maximize benefits while minimizing potential harms.
This research stream connects technical understanding of synthetic biology with ethical, legal, and social considerations to develop governance approaches that promote beneficial applications while addressing safety, security, and equity concerns.
Key Research Areas
Gene Editing Governance
Analyzing governance frameworks for CRISPR and other gene editing technologies, with focus on responsible innovation and risk management.
Biosafety Protocols
Developing and evaluating biosafety standards and protocols for synthetic biology research and applications across different contexts.
Global Governance Approaches
Examining international governance mechanisms for synthetic biology, including treaties, standards, and coordination mechanisms.
Equity in Biotechnology
Analyzing access, benefit-sharing, and equity considerations in synthetic biology applications, particularly for health and agriculture.
Upcoming Research Projects
Gene Drive Governance Framework
2025-2026Developing a comprehensive governance framework for gene drive technologies, addressing risk assessment, stakeholder engagement, and international coordination.
Equitable Access to Therapeutic Gene Editing
2025-2026Analyzing barriers to equitable access to therapeutic gene editing technologies and developing frameworks to promote global health equity.
Focus Areas
Research Details
Established
2025
Desired Publications
Gene Drive Governance Framework
Comprehensive governance principles for gene drive technologies, addressing risk assessment, stakeholder engagement, and international coordination.
Equitable Access to Therapeutic Gene Editing
Analysis of barriers to equitable access to therapeutic gene editing technologies and frameworks to promote global health equity.
Get Involved
We welcome collaboration with researchers, policymakers, and civil society organizations working on synthetic biology governance.
Contact Research Team